Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema
Status:
Not yet recruiting
Trial end date:
2024-08-30
Target enrollment:
Participant gender:
Summary
This trial is a Phase 3 Pivotal, Double-Masked, Randomized, 2-stage, Multicenter Study of the
Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema.
Stage 1 will confirm the safety and efficacy of OCS-01 versus Vehicle alone in subjects with
diabetic macular edema (DME).
Stage 2 will evaluate the efficacy and safety of OCS-01 in subjects with DME.